Software M Mac in Chem
ChemDoodle Update
ChemDoodle 2D has been updated. The main focus is expanded support for inorganic compounds and complexes, including haptic bonds and multi-center attachments, their use in
The latest biotech and pharma news from the trade press, updated every hour and linked straight to the publisher. Follow funding, clinical, deals and more. Every story links straight to its publisher.
Software M Mac in Chem
ChemDoodle 2D has been updated. The main focus is expanded support for inorganic compounds and complexes, including haptic bonds and multi-center attachments, their use in
Clinical
MedCity News
This structural problem calls for a structural solution, requiring no new science, regulation, or data. The post The Trials Were Always There — Patients Just Couldn’t Find Them appeared first on MedCity News.
Software T This Week in Cheminformatics
The Scope Concept from Novartis, SB2025 & FARMA2025, TDiMS and a long list of papers
Software T The Niche
Longeveron is a biotech focused on mesenchymal stromal/stem cells or MSCs. Its big news this year was a report in Cell Stem Cell about a potential benefit for frailty from its product laromestrocel. I’ll talk more about that and my concerns further down. Now Longeveron posted res…
Software
Ground Truths
A Gaping Lack of Evidence for Health Benefits
Industry
BioCentury
BIOCENTURY | PRODUCT DEVELOPMENTFATAL TOXICITIES TEST AUTOIMMUNE CAR T’S SAFETY THESISAutoimmune CAR T developers point to rapid manufacturing, construct design, and patient biology as potential determinants of IEC-HS risk
Regulatory
BioCentury
BIOCENTURY | REGULATIONULTRAGENYX WINS FIRST APPROVAL FOR MPS IIIA, CLOSING A BUMPY FOUR-YEAR PATHTraditional approval shows flexibility on external controls while leaving CBER’s biomarker stance unresolved
Regulatory
BioCentury
BIOCENTURY | REGULATIONEMA’S CHMP BACKS EIGHT NEW MEDICINES IN SEPTEMBERRecommendations include two new ovarian cancer therapies, potential first oral drug for hidradenitis suppurativa, and more
Industry
BioCentury
BIOCENTURY | MANAGEMENT TRACKSSANOFI VET TARJA STENVALL TO LEAD BAVARIAN NORDIC Succeeds longtime CEO Paul Chaplin
Industry G GCBR Organization Updates
Special edition of fellowships, funding calls, and other opportunities to work on reducing biological risks.
Funding
BioCentury
BIOCENTURY | FINANCEELECTRA DIPS AFTER PRICING UPSIZED IPO, BUCKING TREND: PUBLIC EQUITY REPORTPlus: Two more companies line up PIPEs to accompany mergers; Tyra’s follow-on; and more
Regulatory
MedCity News
Ultragenyx Pharmaceutical’s Fayuvi is now the first FDA-approved therapy for the underlying cause of Sanfilippo syndrome type A, an ultra-rare inherited neurological disorder. It’s the second approved gene therapy for Ultragenyx, which specializes in rare disease medicines. The p…
Industry P Pharmaceutical Commerce
The White House said Medicaid programs in all 50 states, D.C. and Puerto Rico now receive MFN prices, with nearly $65 billion in savings over a decade.
Manufacturing B BioProcess International
The move is the latest in a growing list of investments geared at bolstering India’s global footprint.
Manufacturing B BioProcess International
The collaboration will focus on the production of synthetic bone marrow.
Software O Omics! Omics!
This week we hosted the first REAL (Readiness & Engagement For Automated Labs) Summit; today that was followed by Ginkgo Datapoints Summit. Both were fascinating surveys of the leading edge of automated data generation and feeding that data into AI models. That da…
Agriculture
Global Ag Tech Initiative
AgGateway’s Paul Schrimpf and Compass Regulatory’s Samantha Murray explore how shared data standards can improve interoperability, analytics, and agricultural decision-making. The post Speaking the Same Language: Solving Ag Data Interoperability Challenges appeared first on Globa…
Industry P Pharmaceutical Commerce
Rebate delays could force 340B hospitals to pay upfront and wait months for credit, distorting drug spend on the books. Valerie Bandy, PharmD, of Tecsys explains the fallout.
Industry P PLOS Biology
by Mona Nazemi, Bian Yanes, Eric Vancauwenberghe, Ifeoluwa Oyelade, Heather Walker, Elena Rainero Invasive breast and pancreatic cancer cells thrive within a collagen I-rich, poorly perfused extracellular matrix (ECM) network, necessitating robust metabolic adaptation to endure n…
Industry P PLOS Biology
by Tal Gordon, Tom Levy, Chester Jiamu Yu, Benyamin Rosental, Lauren Lubeck, Lucia Manni, Irving L. Weissman, Ayelet Voskoboynik Many tissues harbor quiescent stem cells that activate after injury, yet how local signals regulate this transition is not well understood. The solitar…
Industry
MedCity News
The next evolution in ADHD therapy needs to focus not only on drug efficacy but also on how treatment aligns with the ever-busy and demanding lives of patients, families, and caregivers. The post Extending ADHD Coverage for the Entire Active Day appeared first on MedCity News.
Industry P Pharmaceutical Commerce
In this week's Pharma Pulse, Arkansas independent pharmacies bring an underpayment suit against Express Scripts, Novo Nordisk taps Anthropic for AI-driven drug discovery, and Sanofi, UCB and Opella join AstraZeneca on a supply chain heat decarbonization program.
Software L Latch Bio
Toward More Comprehensive AI Safeguards
Industry S SecureBio
Aggregating reads across CASPER sites recovers national pathogen variant dynamics for norovirus and SARS-CoV-2.
Industry
EMA Press
12 new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended 12 medicines for approval at its September 2026 meeting.The committee recommended…, CHMP statistics Key figures from the September 2026 CHMP meeting are represented in the graphi…
Industry
Bio.News
For decades, Congress has passed legislation to protect Americans from public health emergencies, ranging from national security threats to disease outbreaks and natural disasters, […] The post A national security priority: BIO pushes PAHPA reauthorization in 2026 appeared first…
Industry P Patent Docs
By Kevin E. Noonan – On August 25th, the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office designated as Informative its decision in Ex parte Chowdhury, directed toward what constituted improper Markush groupings (see Ex parte Markush, 1925 Dec. Co…
Industry I In the Pipeline
Here’s a paper that I thought deserved a bit more notice than it’s probably getting - there are people who could use to see it who probably don’t read Inorganic Chemistry very often. It’s about carboranes, which are interesting-looking cage-type clusters of boron and carbon atoms…
Industry
BioCentury
BIOCENTURY | POLITICS, POLICY & LAWTWELVE DAYS TO GO AND PHARMA TARIFF RULES ARE A TOTAL MYSTERYSmall- and mid-sized companies that will have to pay tariffs have no idea about what products will be exempt or how to apply for exemptions
Funding
BioCentury
BIOCENTURY | FINANCESCALE AS STRATEGY: BLACKSTONE’S GALAKATOS ON FUNDING THE HARDEST MILENick Galakatos joins The BioCentury Show to discuss the path from Clarus to a $6.3B fund, and the goal of game-changing bets
Funding
BioCentury
BIOCENTURY | FINANCEWITH TEPEZZA CHALLENGE IN LATE-STAGE STUDY, SLING DRAWS $123M SERIES C: VENTURE REPORTPlus: Circle draws $92.5M round after introducing second development candidate; and more
Software A Asimov Press
Our first podcast!
Funding
MedCity News
North Immunology is going public in a reverse merger with Aethlon Medical. With eczema as the lead indication, the inflammation and immunology biotech aims to show its bispecific antibody offers efficacy and tolerability advantages over Sanofi’s immune disorder juggernaut, Dupixe…
Regulatory
FDA Press Announcements
The U.S. Food and Drug Administration today approved Fayuvi (rebisufligene etisparvovec-hopf), the first treatment for pediatric patients with mucopolysaccharidosis type IIIA (MPS IIIA), also known as Sanfilippo syndrome type A.
Research
Medical Design and Outsourcing
A group of international researchers found that foot-mounted wearable sensors could provide lab-quality gait data from patients with knee osteoarthritis without the use of sophisticated motion-capture cameras. Led by researchers at Yale University, the paper published in JMIR For…
Software P Paired Ends
Standardizing federal biological data to maintain US competitiveness in AI and biotechnology
Industry
Medical Design and Outsourcing
Acquisitions and divestitures drove most of the big changes on Medical Design & Outsourcing‘s 2026 Medtech Big 100 ranking of the world’s largest device companies, and many of those moves involved private equity. In the latest post from our interview with two lawyers who work…
Industry P Pharmaceutical Commerce
Two Labs and Riparian, both part of Envision Pharma Group, work alongside specialty pharma manufacturers at nearly every stage of commercialization — government pricing and compliance, patient support programs, specialty pharmacy selection, trade and distribution, and post-launch…
Agriculture E European Seed
Crop side streams from rapeseed, legumes and potatoes could become new foods for human consumption through the VASCO research project. Wageningen researchers will explore protein extraction, fermentation and supply chain barriers to bring products closer to market. The post Crop…